Carregant...
MON-174 Type II Diabetics Decrease Hypertensive Medication and Improve Blood Pressure in 18 Days
Diabetes and hypertension are often co-morbid conditions leading to adverse health outcomes. Since diabetes and hypertension share common risk factors such as obesity, lifestyle interventions may address the cause of these diseases. An intensive 18-day medical residential lifestyle intervention and...
Guardat en:
| Publicat a: | J Endocr Soc |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6550818/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-174 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|